DRUG DELIVERY: INFUSION PRODUCTS
76 Pages | 21 Exhibits | 2018 Analysis | Forecasts Through 2022
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global infusion drug delivery devices market, including the volumetric, syringe, ambulatory, disposable, implantable, insulin, and enteral pumps segments.What are the key drivers and limiters to the global infusion DDT products market?
Which competitors are leading the market and introducing new technology?
How are technological advancements impacting market growth?
Which areas of the infusion DDT products market are experiencing dynamic growth?
How does the market differ between geographic regions throughout the world?
DRUG DELIVERY: INFUSION PRODUCTS HIGHLIGHTS
- The combined global market for infusion DDT products totaled nearly $9.9bn in 2017, and is expected to climb at a rate of 6.4% over the forecast period.
- Technological advancements, such as devices with needlestick prevention features and dose error reduction software, are a driver of the infusion DDT market.
- The largest absolute gains are expected to occur in the insulin pumps segment, which accounts for nearly half of the total infusion products market and is expected to increase at a CAGR of approximately 9.1% over the forecast period.
- Since the introduction of smart pumps, the formerly flat volumetric pumps market has registered significant gains in dollar volume, driven primarily by the replacement of older volumetric pumps with enhanced-safety, informatics-loaded infusion instruments.
Executive Summary i. Infusion devices market a. Geographic market analysis b. Selected market drivers and limiters c. Volumetric pumps segment d. Syringe pumps segment e. Ambulatory pumps segment f. Disposable pumps segment g. Implantable pumps segment h. Insulin pumps segment i. Enteral pumps segment j. Market leaders ii. Methodology Exhibit ES-1: Infusion drug delivery systems, combined market forecast, by segment ($m), 2017-22 Exhibit ES-2: Infusion drug delivery systems, combined market forecast, by region ($m), 2017-22 1. Infusion Pump Products 1.1 Volumetric pumps 1.1.1 Products 1.2 Syringe pumps 1.2.1 Products 1.3 Ambulatory pumps 1.3.1 Products 1.4 Disposable pumps 1.4.1 Products 1.5 Implantable pumps 1.5.1 Products 1.6 Insulin pumps 1.6.1 Products 1.6.2 Emerging products 1.7 Enteral pumps 1.7.1 Products 1.8 Bibliography Exhibit 1-1: Selected volumetric pumps, 2018 Exhibit 1-2: Selected syringe pumps, 2018 Exhibit 1-3: Selected ambulatory pumps, 2018 Exhibit 1-4: Selected disposable pumps, 2018 Exhibit 1-5: Selected insulin pumps, 2018 Exhibit 1-6: Selected enteral pumps, 2018 2. Infusion Pumps Market 2.1 Volumetric pumps market forecast 2.1.1 Competitive analysis 2.2 Syringe pumps market forecast 2.2.1 Competitive analysis 2.3 Ambulatory pumps market forecast 2.3.1 Competitive analysis 2.4 Disposable pumps market forecast 2.4.1 Competitive analysis 2.5 Implantable pumps market forecast 2.6 Insulin pumps market forecast 2.6.1 Competitive analysis 2.7 Enteral pumps market forecast 2.7.1 Competitive analysis 2.8 Bibliography Exhibit 2-1: Infusion pumps, combined market forecast ($m), 2017-22 Exhibit 2-2: Volumetric pumps and disposables, market forecast ($m), 2017-22 Exhibit 2-3: Volumetric pumps and disposables market, share by supplier, 2017 Exhibit 2-4: Syringe pumps and disposables, market forecast ($m), 2017-22 Exhibit 2-5: Syringe pumps and disposables market, share by supplier, 2017 Exhibit 2-6: Ambulatory pumps, market forecast ($m), 2017-22 Exhibit 2-7: Ambulatory pumps and disposables market, share by supplier, 2017 Exhibit 2-8: Disposable infusion pumps, market forecast ($m), 2017-22 Exhibit 2-9: Disposable infusion pumps market, share by supplier, 2017 Exhibit 2-10: Insulin pumps and disposables, market forecast ($m), 2017-22 Exhibit 2-11: Insulin pumps and disposables market, share by supplier, 2017 Exhibit 2-12: Enteral pumps and disposables, market forecast ($m), 2017-22 Exhibit 2-13: Enteral pumps and disposables market, share by supplier, 2017 Appendix: Company Listing
The following companies are covered in this report:
- Animas Corporation/Johnson & Johnson
- B. Braun Melsungen AG
- Baxter Healthcare/Baxter International, Inc.
- Becton Dickinson and Company
- Calibra Medical, Inc./Johnson & Johnson
- Cardinal Health, Inc.
- Cellnovo SA
- CME America LLC
- Codman & Shurtleff, Inc./Johnson & Johnson
- CR Bard, Inc.
- Epic Medical PTE LTD
- F. Hoffman-La Roche AG
- Fresenius Kabi/Fresenius SE & Co KGaA
- Halyard Health, Inc.
- ICU Medical, Inc.
- Insulet Corporation
- Johnson & Johnson
- Medline Industries, Inc.
- Medtronic PLC
- Moog, Inc.
- Nestle SA
- PFM Medical, Inc.
- RMS Medical Products, Inc.
- Smiths Medical, Inc./Smiths Group PLC
- Stryker Corporation
- Tandem Diabetes Care, Inc.
- Terumo Medical Corporation
- Valeritas, Inc.
- Vygon SA
- WalkMed Infusion LLC
Request Sample
A Single License allows for one person to access the report. A Corporate License allows for multiple individuals within a company to access the report.